Volitionrx (VNRX) Return on Sales (2012 - 2025)

Volitionrx's Return on Sales history runs 8 years deep, the most recent figure standing at 0.01% for Q4 2025.

• Quarterly Return on Sales fell 4.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04% (up 5.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.01% for Q4 2025 at Volitionrx, up from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.05% in Q4 2021 and bottomed at 1.31% in Q4 2023.
• A 5-year average of 0.19% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales surged 10662 bps — and 2023, when it plunged 130 bps.
• Volitionrx's Return on Sales stood at 0.05% in 2021, then sank by 118 bps to 0.01% in 2022, then slumped by 13911 bps to 1.31% in 2023, then soared by 103 bps to 0.04% in 2024, then slumped by 83 bps to 0.01% in 2025.
• Business Quant data shows VNRX's Return on Sales at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.